Watch Stories From Patients
Hear from patients living with geographic atrophy (GA) associated with age‑related macular degeneration (AMD).
This individual, a patient of one of IVERIC bio's steering committee members, did not receive Zimura or any other IVERIC bio drug product.
Carol was a participant in the IVERIC bio GATHER1 Clinical Trial. Listen as she walks you through her clinical trial journey, what inspired her to join the study, and its impact on her life.
ZIMURA® IS AN INVESTIGATIONAL PRODUCT AND HAS NOT BEEN APPROVED BY THE FDA. SAFETY AND EFFICACY OF ZIMURA® FOR AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY HAVE NOT BEEN ESTABLISHED. PLEASE SPEAK TO YOUR DOCTOR ABOUT PARTICIPATING IN THIS TRIAL.
Zimura® (avacincaptad pegol) is a registered trademark of IVERIC bio, Inc.